Literature DB >> 32118603

CORR Insights®: Does a Competing Risk Analysis Show Differences in the Cumulative Incidence of Revision Surgery Between Patients with Oncologic and Nononcologic Conditions After Distal Femur Replacement?

Carlos A Higuera-Rueda1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32118603      PMCID： PMC7170671          DOI： 10.1097/CORR.0000000000001197

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.755


× No keyword cloud information.
  8 in total

1.  Tumor endoprosthesis revision rates increase with peri-operative chemotherapy but are reduced with the use of cemented implant fixation.

Authors:  Luke R Pugh; Paul W Clarkson; Amy E Phillips; David J Biau; Bassam A Masri
Journal:  J Arthroplasty       Date:  2014-01-21       Impact factor: 4.757

2.  Chemotherapy Curtails Bone Formation From Compliant Compression Fixation of Distal Femoral Endoprostheses.

Authors:  Mohammad A Elalfy; Patrick J Boland; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2019-01       Impact factor: 4.176

3.  Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.

Authors:  G N Hortobagyi; R L Theriault; L Porter; D Blayney; A Lipton; C Sinoff; H Wheeler; J F Simeone; J Seaman; R D Knight
Journal:  N Engl J Med       Date:  1996-12-12       Impact factor: 91.245

4.  Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer.

Authors:  P M Ravdin; H A Burris; G Cook; P Eisenberg; M Kane; W A Bierman; J Mortimer; E Genevois; R E Bellet
Journal:  J Clin Oncol       Date:  1995-12       Impact factor: 44.544

5.  Distal femoral replacement with the MML system: a single center experience with an average follow-up of 86 months.

Authors:  Andreas Toepfer; Norbert Harrasser; Paul-Ruben Schwarz; Florian Pohlig; Ulrich Lenze; Heinrich M L Mühlhofer; Ludger Gerdesmeyer; Ruediger von Eisenhart-Rothe; Christian Suren
Journal:  BMC Musculoskelet Disord       Date:  2017-05-22       Impact factor: 2.362

Review 6.  Role of chemotherapy in prostate cancer.

Authors:  Rita Nader; Joelle El Amm; Jeanny B Aragon-Ching
Journal:  Asian J Androl       Date:  2018 May-Jun       Impact factor: 3.285

Review 7.  Megaprosthesis of the knee in tumor and revision surgery.

Authors:  E Pala; G Trovarelli; A Angelini; M Maraldi; A Berizzi; Pietro Ruggieri
Journal:  Acta Biomed       Date:  2017-06-07

8.  Does a Competing Risk Analysis Show Differences in the Cumulative Incidence of Revision Surgery Between Patients with Oncologic and Non-oncologic Conditions After Distal Femur Replacement?

Authors:  Kevin Staats; Klemens Vertesich; Irene K Sigmund; Branden Sosa; Alexandra Kaider; Phillip T Funovics; Reinhard Windhager
Journal:  Clin Orthop Relat Res       Date:  2020-05       Impact factor: 4.755
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.